ROIV
USDRoivant Sciences Ltd. Common Shares
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$19.550
고가
$19.890
저가
$19.315
거래량
9.01M
기업 기본 정보
시가총액
13.6B
산업
생명공학
국가
United Kingdom
거래 통계
평균 거래량
7.66M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.
Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25
Citigroup analyst Samantha Semenkow maintains Roivant Sciences with a Buy and raises the price target from $16 to $25.
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to
